Prognostic Implications and Alterations in Left Atrial Deformation Following Transcatheter Aortic Valve Implantation.

Aortic Stenosis Diastolic Dysfunction Left atrial strain Outcome TAVI

Journal

European heart journal. Cardiovascular Imaging
ISSN: 2047-2412
Titre abrégé: Eur Heart J Cardiovasc Imaging
Pays: England
ID NLM: 101573788

Informations de publication

Date de publication:
10 Jul 2024
Historique:
received: 18 03 2024
revised: 10 06 2024
accepted: 01 07 2024
medline: 10 7 2024
pubmed: 10 7 2024
entrez: 10 7 2024
Statut: aheadofprint

Résumé

To evaluate the prognostic implications of left atrial reservoir strain-defined diastolic dysfunction (LARS-DD) grade in patients undergoing TAVI for severe aortic stenosis (AS) and to determine if post-TAVI LARS was more closely associated with new-onset atrial fibrillation than pre-TAVI LARS. Pre-TAVI LARS-DD was evaluated by speckle-tracking echocardiography and was assigned as grade 0 to 1 (LARS≥24%), grade 2 (LARS≥19 to <24%) and grade 3 (LARS<19%). Patients were followed-up for the primary endpoint of all-cause mortality from the date of TAVI. For the secondary endpoint, patients with pre- and post-TAVI LARS measurements and no history of atrial fibrillation were evaluated for the occurrence of new-onset atrial fibrillation. A total of 601 patients (median age 81 [76-85] years, 53% male) were included. Overall, 169 patients (28%) were LARS-DD grade 0/1, 96 patients (16%) were LARS-DD grade 2 and 336 (56%) were LARS-DD grade 3. Over a median follow-up of 40 (IQR 26-58) months, a total of 258 (43%) patients died. In a comprehensive multivariable Cox regression model, LARS-DD grade was independently associated with all-cause mortality (adjusted HR 1.28 per one-grade increase, 95%CI 1.07-1.53, P=0.007). For the secondary endpoint of new-onset atrial fibrillation, a total of 285 patients were evaluated. Post-TAVI LARS (SDHR 1.14 per 1%<20%, 95%CI 1.05-1.23, P=0.0009), but not pre-TAVI LARS (P=0.93) was independently associated with new-onset atrial fibrillation. Increasing LARS-DD grade was independently associated with long-term post-TAVI survival in patients with severe AS. Post-TAVI LARS was closely related to the occurrence of new-onset atrial fibrillation.

Identifiants

pubmed: 38984693
pii: 7710411
doi: 10.1093/ehjci/jeae170
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© The Author(s) 2024. Published by Oxford University Press on behalf of the European Society of Cardiology.

Auteurs

Steele C Butcher (SC)

Department of Cardiology, Leiden University Medical Center, 2300RC Leiden, The Netherlands.
Department of Cardiology, Royal Perth Hospital, Perth, Western Australia, Australia.

Kensuke Hirasawa (K)

Department of Cardiology, Leiden University Medical Center, 2300RC Leiden, The Netherlands.
Department of Cardiovascular Medicine, Tokyo Medical and Dental University, Tokyo, Japan.

Maria Chiara Meucci (MC)

Department of Cardiology, Leiden University Medical Center, 2300RC Leiden, The Netherlands.
Department of Cardiovascular and Thoracic Sciences, Fondazione Policlinico Universitario A. Gemelli IRCCS, Catholic University of the Sacred Heart, Rome, Italy.

Jan Stassen (J)

Department of Cardiology, Leiden University Medical Center, 2300RC Leiden, The Netherlands.
Department of Cardiology, Jessa Hospital Hasselt, Stadsomvaart 11, 3500 Hasselt, Belgium.

Jurrien H Kuneman (JH)

Department of Cardiology, Leiden University Medical Center, 2300RC Leiden, The Netherlands.

Ana Rita Pereira (AR)

Department of Cardiology, Leiden University Medical Center, 2300RC Leiden, The Netherlands.
Department of Cardiology, Hospital Garcia de Orta, Almada, Portugal.

Frank van der Kley (F)

Department of Cardiology, Leiden University Medical Center, 2300RC Leiden, The Netherlands.

Arend de Weger (A)

Department of Cardio-Thoracic Surgery, Leiden University Medical Center, 2300RC Leiden, The Netherlands.

Philippe J van Rosendael (PJ)

Department of Cardiology, Leiden University Medical Center, 2300RC Leiden, The Netherlands.

Nina Ajmone Marsan (NA)

Department of Cardiology, Leiden University Medical Center, 2300RC Leiden, The Netherlands.

David Playford (D)

School of Medicine, University of Notre Dame, Fremantle, Western Australia, Australia.

Victoria Delgado (V)

Department of Cardiology, Leiden University Medical Center, 2300RC Leiden, The Netherlands.
Heart Institute. Hospital University Germans Trias i Pujol, Badalona, Spain.

Jeroen J Bax (JJ)

Department of Cardiology, Leiden University Medical Center, 2300RC Leiden, The Netherlands.
Heart Center, University of Turku and Turku University Hospital, Turku, Finland.

Classifications MeSH